APO RESEARCH · REPORT
Biologic and Medical Imaging Reagents
Biological and Medical Imaging Reagents are chemicals that clinicians and healthcare providers can determine whether a tumor is malignant or benign, and can locate any metastatic cancer in the body, specifically designed to enhance the image produced by the imaging system.
Product & engineering
Understand the product.
Biological and Medical Imaging Reagents are chemicals that clinicians and healthcare providers can determine whether a tumor is malignant or benign, and can locate any metastatic cancer in the body, specifically designed to enhance the image produced by the imaging system.
Selected research
Market Outlook & Growth Opportunities
Global Biologic and Medical Imaging Reagents Market Outlook and Growth Opportunities 2026
Market perspective
Biological and Medical Imaging Reagents are chemicals that clinicians and healthcare providers can determine whether a tumor is malignant or benign, and can locate any metastatic cancer in the body, specifically designed to enhance the image produced by the imaging system.
The global well-known brands in Biologic and Medical Imaging Reagents include Cardinal Health(6.77%), Bracco(5.41%), Bayer HealthCare(3.48%), Curium Pharma(2.02%), Hengrui Medicine(2.67%), GE Healthcare(2.53%), Lantheus Medical Imaging(2.01%), Novartis (AAA)(2.77%), Thermo Fisher Scientific(2.16%), Jubilant DraxImage(1.63%), PerkinElmer(1.44%), Guerbet(1.75%), Nihon Medi-Physics(1.75%), YRPG(1.09%) and Others(62.52%).
The application area of Biologic and Medical Imaging Reagents include Hospitals, Clinics and Other.
Read the full market overview
In terms of types, Biologic and Medical Imaging Reagents can be divided into Nuclear Imaging (PET & SPECT) Reagents, Magnetic Resonance Imaging (MRI) Reagents, Fluorescence Imaging Reagents, Ultrasound and X-ray Contrast Reagents and Other.
On basis of geography, Biologic and Medical Imaging Reagents are manufactured in North America, Europe, China and Japan.
This report provides an overview of the global Biologic and Medical Imaging Reagents market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biologic and Medical Imaging Reagents and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biologic and Medical Imaging Reagents revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biologic and Medical Imaging Reagents market.
Biologic and Medical Imaging Reagents Segment by Company
Cardinal Health
Bracco
Bayer HealthCare
Curium Pharma
Hengrui Medicine
GE Healthcare
Lantheus Medical Imaging
Novartis (AAA)
Thermo Fisher Scientific
Jubilant DraxImage
PerkinElmer
Guerbet
Nihon Medi-Physics
YRPG
Biologic and Medical Imaging Reagents Segment by Type
Nuclear Imaging (PET & SPECT) Reagents
Magnetic Resonance Imaging (MRI) Reagents
Fluorescence Imaging Reagents
Ultrasound and X-ray Contrast Reagents
Other
Biologic and Medical Imaging Reagents Segment by Application
Hospitals
Clinics
Other
Biologic and Medical Imaging Reagents Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Biologic and Medical Imaging Reagents status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Biologic and Medical Imaging Reagents key companies, revenue, market share, and recent developments.
3. To split the Biologic and Medical Imaging Reagents breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Biologic and Medical Imaging Reagents market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Biologic and Medical Imaging Reagents significant trends, drivers, influence factors in global and regions.
6. To analyze Biologic and Medical Imaging Reagents competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologic and Medical Imaging Reagents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biologic and Medical Imaging Reagents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologic and Medical Imaging Reagents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biologic and Medical Imaging Reagents industry.
Chapter 3: Detailed analysis of Biologic and Medical Imaging Reagents company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Biologic and Medical Imaging Reagents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Biologic and Medical Imaging Reagents in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Biologic and Medical Imaging Reagents Industry Trends
Table 2. Biologic and Medical Imaging Reagents Industry Drivers
Table 3. Biologic and Medical Imaging Reagents Industry Opportunities and Challenges
Table 4. Biologic and Medical Imaging Reagents Industry Restraints
Table 5. Global Biologic and Medical Imaging Reagents Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Biologic and Medical Imaging Reagents Revenue Share by Company (2021-2026)
Table 7. Global Biologic and Medical Imaging Reagents Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Biologic and Medical Imaging Reagents Key Company Manufacturing Base & Headquarters
Table 9. Global Biologic and Medical Imaging Reagents Company, Product Type & Application
Table 10. Global Biologic and Medical Imaging Reagents Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Biologic and Medical Imaging Reagents by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Nuclear Imaging (PET & SPECT) Reagents
Table 15. Significant Companies of Magnetic Resonance Imaging (MRI) Reagents
Table 16. Significant Companies of Fluorescence Imaging Reagents
Table 17. Significant Companies of Ultrasound and X-ray Contrast Reagents
Table 18. Significant Companies of Other
Table 19. Global Biologic and Medical Imaging Reagents Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 20. Global Biologic and Medical Imaging Reagents Sales Value by Type (2021-2026) & (US$ Million)
Table 21. Global Biologic and Medical Imaging Reagents Sales Value by Type (2027-2032) & (US$ Million)
Table 22. Global Biologic and Medical Imaging Reagents Sales Value Share by Type (2021-2026)
Table 23. Global Biologic and Medical Imaging Reagents Sales Value Share by Type (2027-2032)
Table 24. Significant Companies of Hospitals
Table 25. Significant Companies of Clinics
Table 26. Significant Companies of Other
Table 27. Global Biologic and Medical Imaging Reagents Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 28. Global Biologic and Medical Imaging Reagents Sales Value by Application (2021-2026) & (US$ Million)
Table 29. Global Biologic and Medical Imaging Reagents Sales Value by Application (2027-2032) & (US$ Million)
Table 30. Global Biologic and Medical Imaging Reagents Sales Value Share by Application (2021-2026)
Table 31. Global Biologic and Medical Imaging Reagents Sales Value Share by Application (2027-2032)
Table 32. Global Biologic and Medical Imaging Reagents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 33. Global Biologic and Medical Imaging Reagents Sales Value by Region (2021-2026) & (US$ Million)
Table 34. Global Biologic and Medical Imaging Reagents Sales Value Share by Region (2021-2026)
Table 35. Global Biologic and Medical Imaging Reagents Sales Value by Region (2027-2032) & (US$ Million)
Table 36. Global Biologic and Medical Imaging Reagents Sales Value Share by Region (2027-2032)
Table 37. Global Biologic and Medical Imaging Reagents Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 38. Global Biologic and Medical Imaging Reagents Sales Value by Country (2021-2026) & (US$ Million)
Table 39. Global Biologic and Medical Imaging Reagents Sales Value Market Share by Country (2021-2026)
Table 40. Global Biologic and Medical Imaging Reagents Sales Value by Country (2027-2032) & (US$ Million)
Table 41. Global Biologic and Medical Imaging Reagents Sales Value Market Share by Country (2027-2032)
Table 42. Cardinal Health Company Information
Table 43. Cardinal Health Business Overview
Table 44. Cardinal Health Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2021-2026)
Table 45. Cardinal Health Biologic and Medical Imaging Reagents Product Portfolio
Table 46. Cardinal Health Recent Development
Table 47. Bracco Company Information
Table 48. Bracco Business Overview
Table 49. Bracco Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2021-2026)
Table 50. Bracco Biologic and Medical Imaging Reagents Product Portfolio
Table 51. Bracco Recent Development
Table 52. Bayer HealthCare Company Information
Table 53. Bayer HealthCare Business Overview
Table 54. Bayer HealthCare Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2021-2026)
Table 55. Bayer HealthCare Biologic and Medical Imaging Reagents Product Portfolio
Table 56. Bayer HealthCare Recent Development
Table 57. Curium Pharma Company Information
Table 58. Curium Pharma Business Overview
Table 59. Curium Pharma Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2021-2026)
Table 60. Curium Pharma Biologic and Medical Imaging Reagents Product Portfolio
Table 61. Curium Pharma Recent Development
Table 62. Hengrui Medicine Company Information
Table 63. Hengrui Medicine Business Overview
Table 64. Hengrui Medicine Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2021-2026)
Table 65. Hengrui Medicine Biologic and Medical Imaging Reagents Product Portfolio
Table 66. Hengrui Medicine Recent Development
Table 67. GE Healthcare Company Information
Table 68. GE Healthcare Business Overview
Table 69. GE Healthcare Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2021-2026)
Table 70. GE Healthcare Biologic and Medical Imaging Reagents Product Portfolio
Table 71. GE Healthcare Recent Development
Table 72. Lantheus Medical Imaging Company Information
Table 73. Lantheus Medical Imaging Business Overview
Table 74. Lantheus Medical Imaging Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2021-2026)
Table 75. Lantheus Medical Imaging Biologic and Medical Imaging Reagents Product Portfolio
Table 76. Lantheus Medical Imaging Recent Development
Table 77. Novartis (AAA) Company Information
Table 78. Novartis (AAA) Business Overview
Table 79. Novartis (AAA) Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2021-2026)
Table 80. Novartis (AAA) Biologic and Medical Imaging Reagents Product Portfolio
Table 81. Novartis (AAA) Recent Development
Table 82. Thermo Fisher Scientific Company Information
Table 83. Thermo Fisher Scientific Business Overview
Table 84. Thermo Fisher Scientific Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2021-2026)
Table 85. Thermo Fisher Scientific Biologic and Medical Imaging Reagents Product Portfolio
Table 86. Thermo Fisher Scientific Recent Development
Table 87. Jubilant DraxImage Company Information
Table 88. Jubilant DraxImage Business Overview
Table 89. Jubilant DraxImage Biologic and Medical Imaging Reagents Revenue (US$ Million) and Gross Margin (2021-2026)
Table 90. Jubilant DraxImage Biologic and Medical Imaging Reagents Product Portfolio
Table 91. Jubilant DraxImage Recent Development
Table 92. PerkinElmer Company Information
Table 93. PerkinElmer Business Overview
Table 94. PerkinElmer Biologic and Medical Imaging Reagents Sales (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 95. PerkinElmer Biologic and Medical Imaging Reagents Product Portfolio
Table 96. PerkinElmer Recent Development
Table 97. Guerbet Company Information
Table 98. Guerbet Business Overview
Table 99. Guerbet Biologic and Medical Imaging Reagents Sales (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 100. Guerbet Biologic and Medical Imaging Reagents Product Portfolio
Table 101. Guerbet Recent Development
Table 102. Nihon Medi-Physics Company Information
Table 103. Nihon Medi-Physics Business Overview
Table 104. Nihon Medi-Physics Biologic and Medical Imaging Reagents Sales (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 105. Nihon Medi-Physics Biologic and Medical Imaging Reagents Product Portfolio
Table 106. Nihon Medi-Physics Recent Development
Table 107. YRPG Company Information
Table 108. YRPG Business Overview
Table 109. YRPG Biologic and Medical Imaging Reagents Sales (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 110. YRPG Biologic and Medical Imaging Reagents Product Portfolio
Table 111. YRPG Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Authors List of This Report
Table 114. Secondary Sources
Table 115. Primary Sources
List of Figures
Figure 1. Biologic and Medical Imaging Reagents Product Image
Figure 2. Global Biologic and Medical Imaging Reagents Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Biologic and Medical Imaging Reagents Market Size (2021-2032) & (US$ Million)
Figure 4. Global Biologic and Medical Imaging Reagents Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Nuclear Imaging (PET & SPECT) Reagents Image
Figure 8. Magnetic Resonance Imaging (MRI) Reagents Image
Figure 9. Fluorescence Imaging Reagents Image
Figure 10. Ultrasound and X-ray Contrast Reagents Image
Figure 11. Other Image
Figure 12. Global Biologic and Medical Imaging Reagents Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 13. Global Biologic and Medical Imaging Reagents Sales Value Share 2021 VS 2025 VS 2032
Figure 14. Global Biologic and Medical Imaging Reagents Sales Value Share by Type (2021-2032)
Figure 15. Hospitals Image
Figure 16. Clinics Image
Figure 17. Other Image
Figure 18. Global Biologic and Medical Imaging Reagents Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 19. Global Biologic and Medical Imaging Reagents Sales Value Share 2021 VS 2025 VS 2032
Figure 20. Global Biologic and Medical Imaging Reagents Sales Value Share by Application (2021-2032)
Figure 21. Global Biologic and Medical Imaging Reagents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 22. Global Biologic and Medical Imaging Reagents Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 23. North America Biologic and Medical Imaging Reagents Sales Value (2021-2032) & (US$ Million)
Figure 24. North America Biologic and Medical Imaging Reagents Sales Value Share by Country (%), 2025 VS 2032
Figure 25. Europe Biologic and Medical Imaging Reagents Sales Value (2021-2032) & (US$ Million)
Figure 26. Europe Biologic and Medical Imaging Reagents Sales Value Share by Country (%), 2025 VS 2032
Figure 27. Asia-Pacific Biologic and Medical Imaging Reagents Sales Value (2021-2032) & (US$ Million)
Figure 28. Asia-Pacific Biologic and Medical Imaging Reagents Sales Value Share by Country (%), 2025 VS 2032
Figure 29. South America Biologic and Medical Imaging Reagents Sales Value (2021-2032) & (US$ Million)
Figure 30. South America Biologic and Medical Imaging Reagents Sales Value Share by Country (%), 2025 VS 2032
Figure 31. Middle East & Africa Biologic and Medical Imaging Reagents Sales Value (2021-2032) & (US$ Million)
Figure 32. Middle East & Africa Biologic and Medical Imaging Reagents Sales Value Share by Country (%), 2025 VS 2032
Figure 33. USA Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 34. USA Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 35. USA Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 36. Canada Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 37. Canada Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 38. Canada Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 39. Mexico Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 40. Mexico Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 41. Mexico Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 42. Germany Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 43. Germany Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 44. Germany Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 45. France Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 46. France Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 47. France Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 48. U.K. Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 49. U.K. Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 50. U.K. Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 51. Italy Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 52. Italy Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 53. Italy Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 54. Spain Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 55. Spain Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 56. Spain Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 57. Russia Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 58. Russia Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 59. Russia Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 60. Netherlands Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 61. Netherlands Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 62. Netherlands Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 63. Nordic Countries Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 64. Nordic Countries Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 65. Nordic Countries Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 66. China Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 67. China Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 68. China Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 69. Japan Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 70. Japan Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 71. Japan Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 72. South Korea Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 73. South Korea Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 74. South Korea Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 75. India Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 76. India Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 77. India Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 78. Australia Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 79. Australia Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 80. Australia Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 81. Southeast Asia Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 82. Southeast Asia Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 83. Southeast Asia Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 84. Brazil Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 85. Brazil Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 86. Brazil Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 87. Argentina Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 88. Argentina Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 89. Argentina Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 90. Chile Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 91. Chile Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 92. Chile Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 93. Colombia Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 94. Colombia Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 95. Colombia Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 96. Peru Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 97. Peru Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 98. Peru Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 99. Saudi Arabia Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 100. Saudi Arabia Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 101. Saudi Arabia Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 102. Israel Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 103. Israel Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 104. Israel Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 105. UAE Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 106. UAE Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 107. UAE Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 108. Turkey Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 109. Turkey Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 110. Turkey Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 111. Iran Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 112. Iran Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 113. Iran Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 114. Egypt Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 115. Egypt Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 116. Egypt Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 117. Years Considered
Figure 118. Research Process
Figure 119. Key Executives Interviewed
Scope & coverage.
Types
- Nuclear Imaging (PET & SPECT) Reagents
- Magnetic Resonance Imaging (MRI) Reagents
- Fluorescence Imaging Reagents
- Ultrasound and X-ray Contrast Reagents
- Other
Applications
- Hospitals
- Clinics
- Other
Companies covered
- Cardinal Health
- Bracco
- Bayer HealthCare
- Curium Pharma
- Hengrui Medicine
- GE Healthcare
- Lantheus Medical Imaging
- Novartis (AAA)
- Thermo Fisher Scientific
- Jubilant DraxImage
- PerkinElmer
- Guerbet
- Nihon Medi-Physics
- YRPG
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Biologic and Medical Imaging Reagents Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Biologic and Medical Imaging Reagents Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Biologic and Medical Imaging Reagents Market Dynamics
- 2.1 Biologic and Medical Imaging Reagents Industry Trends
- 2.2 Biologic and Medical Imaging Reagents Industry Drivers
- 2.3 Biologic and Medical Imaging Reagents Industry Opportunities and Challenges
- 2.4 Biologic and Medical Imaging Reagents Industry Restraints
3 Biologic and Medical Imaging Reagents Market by Company
- 3.1 Global Biologic and Medical Imaging Reagents Company Revenue Ranking in 2025
- 3.2 Global Biologic and Medical Imaging Reagents Revenue by Company (2021-2026)
- 3.3 Global Biologic and Medical Imaging Reagents Company Ranking (2024-2026)
- 3.4 Global Biologic and Medical Imaging Reagents Company Manufacturing Base and Headquarters
- 3.5 Global Biologic and Medical Imaging Reagents Company Product Type and Application
- 3.6 Global Biologic and Medical Imaging Reagents Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Biologic and Medical Imaging Reagents Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Biologic and Medical Imaging Reagents Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Biologic and Medical Imaging Reagents Market by Type
- 4.1 Biologic and Medical Imaging Reagents Type Introduction
- 4.1.1 Nuclear Imaging (PET & SPECT) Reagents
- 4.1.2 Magnetic Resonance Imaging (MRI) Reagents
- 4.1.3 Fluorescence Imaging Reagents
- 4.1.4 Ultrasound and X-ray Contrast Reagents
- 4.1.5 Other
- 4.2 Global Biologic and Medical Imaging Reagents Sales Value by Type
- 4.2.1 Global Biologic and Medical Imaging Reagents Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Biologic and Medical Imaging Reagents Sales Value by Type (2021-2032)
- 4.2.3 Global Biologic and Medical Imaging Reagents Sales Value Share by Type (2021-2032)
5 Biologic and Medical Imaging Reagents Market by Application
- 5.1 Biologic and Medical Imaging Reagents Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.1.3 Other
- 5.2 Global Biologic and Medical Imaging Reagents Sales Value by Application
- 5.2.1 Global Biologic and Medical Imaging Reagents Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Biologic and Medical Imaging Reagents Sales Value by Application (2021-2032)
- 5.2.3 Global Biologic and Medical Imaging Reagents Sales Value Share by Application (2021-2032)
6 Biologic and Medical Imaging Reagents Regional Value Analysis
- 6.1 Global Biologic and Medical Imaging Reagents Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Biologic and Medical Imaging Reagents Sales Value by Region (2021-2032)
- 6.2.1 Global Biologic and Medical Imaging Reagents Sales Value by Region: 2021-2026
- 6.2.2 Global Biologic and Medical Imaging Reagents Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Biologic and Medical Imaging Reagents Sales Value (2021-2032)
- 6.3.2 North America Biologic and Medical Imaging Reagents Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Biologic and Medical Imaging Reagents Sales Value (2021-2032)
- 6.4.2 Europe Biologic and Medical Imaging Reagents Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Biologic and Medical Imaging Reagents Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Biologic and Medical Imaging Reagents Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Biologic and Medical Imaging Reagents Sales Value (2021-2032)
- 6.6.2 South America Biologic and Medical Imaging Reagents Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Biologic and Medical Imaging Reagents Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Biologic and Medical Imaging Reagents Sales Value Share by Country, 2025 VS 2032
7 Biologic and Medical Imaging Reagents Country-level Value Analysis
- 7.1 Global Biologic and Medical Imaging Reagents Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Biologic and Medical Imaging Reagents Sales Value by Country (2021-2032)
- 7.2.1 Global Biologic and Medical Imaging Reagents Sales Value by Country (2021-2026)
- 7.2.2 Global Biologic and Medical Imaging Reagents Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.7.2 France Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.14.2 China Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.17.2 India Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Biologic and Medical Imaging Reagents Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Biologic and Medical Imaging Reagents Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Biologic and Medical Imaging Reagents Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Cardinal Health
- 8.1.1 Cardinal Health Company Information
- 8.1.2 Cardinal Health Business Overview
- 8.1.3 Cardinal Health Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
- 8.1.4 Cardinal Health Biologic and Medical Imaging Reagents Product Portfolio
- 8.1.5 Cardinal Health Recent Developments
- 8.2 Bracco
- 8.2.1 Bracco Company Information
- 8.2.2 Bracco Business Overview
- 8.2.3 Bracco Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
- 8.2.4 Bracco Biologic and Medical Imaging Reagents Product Portfolio
- 8.2.5 Bracco Recent Developments
- 8.3 Bayer HealthCare
- 8.3.1 Bayer HealthCare Company Information
- 8.3.2 Bayer HealthCare Business Overview
- 8.3.3 Bayer HealthCare Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
- 8.3.4 Bayer HealthCare Biologic and Medical Imaging Reagents Product Portfolio
- 8.3.5 Bayer HealthCare Recent Developments
- 8.4 Curium Pharma
- 8.4.1 Curium Pharma Company Information
- 8.4.2 Curium Pharma Business Overview
- 8.4.3 Curium Pharma Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
- 8.4.4 Curium Pharma Biologic and Medical Imaging Reagents Product Portfolio
- 8.4.5 Curium Pharma Recent Developments
- 8.5 Hengrui Medicine
- 8.5.1 Hengrui Medicine Company Information
- 8.5.2 Hengrui Medicine Business Overview
- 8.5.3 Hengrui Medicine Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
- 8.5.4 Hengrui Medicine Biologic and Medical Imaging Reagents Product Portfolio
- 8.5.5 Hengrui Medicine Recent Developments
- 8.6 GE Healthcare
- 8.6.1 GE Healthcare Company Information
- 8.6.2 GE Healthcare Business Overview
- 8.6.3 GE Healthcare Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
- 8.6.4 GE Healthcare Biologic and Medical Imaging Reagents Product Portfolio
- 8.6.5 GE Healthcare Recent Developments
- 8.7 Lantheus Medical Imaging
- 8.7.1 Lantheus Medical Imaging Company Information
- 8.7.2 Lantheus Medical Imaging Business Overview
- 8.7.3 Lantheus Medical Imaging Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
- 8.7.4 Lantheus Medical Imaging Biologic and Medical Imaging Reagents Product Portfolio
- 8.7.5 Lantheus Medical Imaging Recent Developments
- 8.8 Novartis (AAA)
- 8.8.1 Novartis (AAA) Company Information
- 8.8.2 Novartis (AAA) Business Overview
- 8.8.3 Novartis (AAA) Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
- 8.8.4 Novartis (AAA) Biologic and Medical Imaging Reagents Product Portfolio
- 8.8.5 Novartis (AAA) Recent Developments
- 8.9 Thermo Fisher Scientific
- 8.9.1 Thermo Fisher Scientific Company Information
- 8.9.2 Thermo Fisher Scientific Business Overview
- 8.9.3 Thermo Fisher Scientific Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
- 8.9.4 Thermo Fisher Scientific Biologic and Medical Imaging Reagents Product Portfolio
- 8.9.5 Thermo Fisher Scientific Recent Developments
- 8.10 Jubilant DraxImage
- 8.10.1 Jubilant DraxImage Company Information
- 8.10.2 Jubilant DraxImage Business Overview
- 8.10.3 Jubilant DraxImage Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
- 8.10.4 Jubilant DraxImage Biologic and Medical Imaging Reagents Product Portfolio
- 8.10.5 Jubilant DraxImage Recent Developments
- 8.11 PerkinElmer
- 8.11.1 PerkinElmer Company Information
- 8.11.2 PerkinElmer Business Overview
- 8.11.3 PerkinElmer Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
- 8.11.4 PerkinElmer Biologic and Medical Imaging Reagents Product Portfolio
- 8.11.5 PerkinElmer Recent Developments
- 8.12 Guerbet
- 8.12.1 Guerbet Company Information
- 8.12.2 Guerbet Business Overview
- 8.12.3 Guerbet Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
- 8.12.4 Guerbet Biologic and Medical Imaging Reagents Product Portfolio
- 8.12.5 Guerbet Recent Developments
- 8.13 Nihon Medi-Physics
- 8.13.1 Nihon Medi-Physics Company Information
- 8.13.2 Nihon Medi-Physics Business Overview
- 8.13.3 Nihon Medi-Physics Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
- 8.13.4 Nihon Medi-Physics Biologic and Medical Imaging Reagents Product Portfolio
- 8.13.5 Nihon Medi-Physics Recent Developments
- 8.14 YRPG
- 8.14.1 YRPG Company Information
- 8.14.2 YRPG Business Overview
- 8.14.3 YRPG Biologic and Medical Imaging Reagents Revenue and Gross Margin (2021-2026)
- 8.14.4 YRPG Biologic and Medical Imaging Reagents Product Portfolio
- 8.14.5 YRPG Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst